Home » Authors » Jean-Baptiste Reiland, MSc
Project Manager, Global Public Affairs, Sanofi
Last update: 14/03/2025
Go Back
🖨️ Print
The extended stability studies of anticancer therapies published in 2024 cover 21 small molecules across 10 parenteral drug groups in oncology.
More about Special Report - Stability Studies →
Volume 13 / Year 2024 / Issue 3
Read more →
Volume 13 / Year 2024 / Issue 2
Forthcoming Issue ▸
Recommend to a friend ▸
Request sample issue ▸
RSS feed ▸
Online First ▸
For Authors ▸
Call for Papers ▸
About GaBI Journal ▸
Subscribe ▸
Quick Links ▸
Sign up today for the weekly briefing on the latest developments in generic and biosimilar medicines!
Advertise ▸
Educational Workshops ▸
Educational Series ▸
Current Issue ▸
Fast Track ▸
Glossary of Key Terms / FAQs ▸
Guidance for Guest Authors ▸
Information for Authors ▸
Library Recommendation Form ▸
Submit a Manuscript ▸
Subscribe to a print or PDF copy of GaBI Journal ▸
Support GaBI !!! ▸
Sponsor a Supplement ▸
Reprints ▸
Notifications
